Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Targeting Aerobic and Facultative Gram-negative Bacilli, Gram-positive Anaerobes and Select Agent Surrogate Strains
Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Targeting Aerobic and Facultative Gram-negative Bacilli, Gram-positive Anaerobes and Select Agent Surrogate Strains, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC
